Roche Diagnostics Steps Up Services, Eyes Laboratory Tie-up
This article was originally published in PharmAsia News
Executive Summary
Roche Diagnostics recently disclosed that it will step up efforts to get a slice of China's RMB 850 billion healthcare reform pie. Although the company's product portfolio includes devices catering to China's small- and mid-sized hospitals and rural specialists, it enjoys no price advantage. To address this, the firm will compete by providing high-level services. In addition, Roche Diagnostics will collaborate with local independent laboratories to meet the outsourced testing needs of small hospitals that do not own clinical testing departments. The company does not discount the possibility of acquisitions or partnerships to enhance its R&D in China. (Click here for more - Chinese Language)